23rd October 2020

MHRA and EMA latest guidance on Brexit

As at 23 October 2020, the situation regarding a Deal or No Deal Brexit is extremely fluid. As such, rather than bombard you with our guesses […]
12th February 2020

What happens after Brexit for Pharmacovigilance and Regulatory?

7th February 2020

Pharmacovigilance (QPPV) provision post-Brexit

There has been and still is a huge amount of confusion regarding the requirements for establishing a UK QPPV following the UK’s exit from Europe on […]
15th January 2020

Is your pharmaceutical company Brexit ready?

Pure Drug Safety is ready to help you with your post Brexit pharmacovigilance and regulatory requirements – deal or no deal. Just call us now for […]